← Leaderboards
Josep M Llovet
Icahn School Of Medicine At Mount Sinai
$2,681,666
Attributed
$2,681,666
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $479.5K · FY2007–25$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,681,666 · 2
By mechanism
R01$2,681,666 · 2
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Amaia Lujambio$5,368,450
- Ernesto Guccione$11,143,318
- Poulikos I Poulikakos$5,543,909
- Alexander Real$189,336
- Gabrielle Alexia Price$146,660
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMapsMalignant NeoplasmsProspectiveSamplingMolecularGenomicsIncidenceMutationPrimary Carcinoma Of The Liver CellsTissuesTumorPathway InteractionsCohortEtiologyGenesCancer EtiologyHepatocarcinogenesisDisseminated Malignant NeoplasmDisease ProgressionDna Microarray ChipDiagnosticDetectionDiagnosis
Grant awards (8)
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma$479,492
R01 · FY2025 · CA · contact PI
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma$455,518
R01 · FY2024 · CA · contact PI
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma$473,881
R01 · FY2023 · CA · contact PI
Integrative genomic analysis in hepatocellular carcinoma$242,852
R01 · FY2011 · DK · contact PI
Integrative genomic analysis in hepatocellular carcinoma$245,305
R01 · FY2010 · DK · contact PI
Integrative genomic analysis in hepatocellular carcinoma$251,025
R01 · FY2009 · DK · contact PI
Integrative genomic analysis in hepatocellular carcinoma$258,082
R01 · FY2008 · DK · contact PI
Integrative genomic analysis in hepatocellular carcinoma$275,511
R01 · FY2007 · DK · contact PI